Global Anti-snoring Device Market Trends and Drivers, Restraints, and Opportunities 2018-2024

  • ID: 4470732
  • Report
  • Region: Global
  • 65 pages
  • Infoholic Research LLP
1 of 6

FEATURED COMPANIES

  • GlaxoSmithKline plc
  • Hivox Biotek Inc.
  • Meditas
  • MPowerx
  • Rhinomed Ltd
  • Sleep Well Enjoy Life Ltd
  • MORE
Overview:

Snoring is a harsh noise formed due to the trembling of the muscular palate and pillars of the oropharyngeal inlet during sleep. A person is described as a habitual snorer if there is an occurrence of loud snoring at least three times in a week. This is majorly connected with obstructive sleep apnea (OSA). These habitual snorers experience excessive sleepiness in the daytime and can develop systemic hypertension in those aged below 50 years. Recently, studies have suggested that snoring can have risks of carotid atherosclerosis also. There have been many international epidemiological studies to establish the prevalence of habitual snoring.

When snoring is left untreated, it has multiple adverse consequences such as sleep apnea, stroke, systemic hypertension, atrial fibrillation, coronary artery disease, and others. Anti-snoring devices and surgery are the two types of treatment options available currently. These two methods help in the prevention of snoring and improve the quality of sleep. Uvulopalatopharyngoplasty surgery, radiofrequency ablation surgery, adenoidectomy surgery, maxillo-mandibular surgeries, and tonsillectomy are the alternatives for anti-snoring devices in the market.

The significant factors driving the progress of the market are increasing awareness about ill effects of snoring, mounting geriatric and obese population, increase in the number of smokers and alcoholics, and a huge volume of snoring population. However, the meager effectiveness of present anti-snoring devices accessible in the marketplace and the availability of alternative treatments for snoring are some of the factors hampering the market growth.

Market Analysis:

The “Global Anti-snoring Devices Market” is estimated to witness a CAGR of 9.8% during the forecast period 2018-2024. The market is analyzed based on three segments - products, end-users, and regions.

Regional Analysis: The regions covered in the report are North America, Europe, Asia Pacific, and Rest of the World (ROW). North America holds the major share of the anti-snoring devices market, followed by Europe. These two regions together hold three-fourth of revenue in the market. Asia Pacific is expected to have the fastest growth rate due to high infectious diseases prevalence, large patient pool, and increasing awareness. This is followed by Rest of the World in terms of the growth rate during the forecast period.

Product Analysis:

Oral appliances, nasal devices, position control devices, chin straps, and EPAP devices are the types of products in the anti-snoring market. Mandibular advancement devices (MADs) and tongue retaining devices are the types of oral appliances in the market. Nasal dilators and nasal strips are the two types of nasal devices. Position pillows, anti-snoring belt, and bottom lines are the types of position control devices.

End-users Analysis:

The hospitals & clinics is the largest application segment in 2017. The sleep clinics that recommend anti-snoring oral appliances to their patients have shown a positive success rate as high as 94%. However, this success rate may vary between individuals. Yet, there has been an increase in the demand for the home healthcare during the forecast period. This increase in home care has given rise to many technological advanced and portable products.

Key Players:

Sleeping Well LLC, Apnea Sciences Corporation, Tomed GmbH, Sleep Well Enjoy Life Ltd., MEDiTAS, and GlaxoSmithKline are the key players in the market. SomnoMed Ltd., MPowerx, Thervent, Rhinomed Ltd., Hivox Biotek Inc., and Zyppah are other predominate & niche players.

Competitive Analysis:

The oral appliances are the most used anti-snoring devices and held more than half of the share in 2017. Some of the key players in this segment include Apnea Sciences Corporation, Sleeping Well, Sleep Well Enjoy Life, Tomed GmbH, and MEDiTAS. Nasal devices are next to the oral appliances, which is led by GlaxoSmithKline.

Many companies are concentrating on product innovation to reinforce their spot in the market. For instance, Oventus Medical, based in Australia, has recently launched a 3D printed anti-snoring device named O2Vent that can be customized based on an individual’s need. It is a lightweight titanium device and can help patients stop snoring by delivering air to the back of his or her mouth. Such modernizations hold the great potential for the success of the company in the market.

Benefits:

The report provides complete details about the usage and adoption rate of anti-snoring devices in various therapeutic verticals and regions. With that, key stakeholders can know about the major trends, drivers, investments, and vertical player’s initiatives. Moreover, the report provides details about the major challenges that are going to impact on the market growth. Additionally, the report gives the complete details about the key business opportunities to key stakeholders to expand their business and capture the revenue in the specific verticals to analyze before investing or expanding the business in this market.
READ MORE
Note: Product cover images may vary from those shown
2 of 6

FEATURED COMPANIES

  • GlaxoSmithKline plc
  • Hivox Biotek Inc.
  • Meditas
  • MPowerx
  • Rhinomed Ltd
  • Sleep Well Enjoy Life Ltd
  • MORE
1. Industry Outlook
1.1 Industry Overview
1.2 Industry Trends

2. Report Outline
2.1 Report Scope
2.2 Report Summary
2.3 Research Methodology
2.4 Report Assumptions

3. Market Snapshot
3.1 Segmented Addressable Market
3.2 Industry Trends
3.3 Related Markets
3.3.1 Nebulizers
3.3.2 Continuous positive airway pressure (CPAP)
3.3.3 Sleep Apnea
3.3.4 Pulmonary Medicine

4. Market Outlook
4.1 Market Definition
4.2 Market Overview
4.3 Causes of Snoring
4.4 Market Segmentation
4.5 Porter 5(Five) Forces
4.6 PEST Analysis

5. Market Characteristics
5.1 Market Dynamics
5.1.1 Drivers
5.1.1.1 Increasing usage of oral appliances
5.1.1.2 Growing awareness about ill-effects of snoring
5.1.1.3 High prevalence of tobacco smoking
5.1.1.4 In expensive nature of the devices
5.1.2 Opportunities
5.1.2.1 Rising Ageing and Obese Population
5.1.2.2 Emerging Markets in Developing Countries
5.1.3 Restraints
5.1.3.1 Poor Effectiveness of Existing Anti-Snoring Devices in The Market
5.1.3.2 Alternative Treatment for Snoring
5.2 DRO - Impact Analysis
5.3 Key Stakeholders

6. Product: Market Size and Analysis
6.1 Overview
6.2 Oral Appliances
6.2.1 Mandibular Advancement Devices (MAD)
6.2.2 Tongue Stabilizing Devices
6.3 Nasal Devices
6.3.1 Nasal Dilator
6.3.2 Nasal Strips
6.4 Position Control Devices
6.5 Chin Straps
6.6 EPAP Therapy Devices

7. End-users: Market Size and Analysis
7.1 Overview
7.2 Hospitals and clinics
7.3 Home Care

8. Regions: Market Size and Analysis
8.1 Overview
8.2 North America
8.2.1 Overview
8.2.2 United States
8.2.3 Canada
8.3 Europe
8.3.1 Overview
8.3.2 UK
8.3.3 Germany
8.3.4 France
8.4 Asia Pacific
8.4.1 Overview
8.4.2 India
8.4.3 Japan
8.4.4 China
8.4.5 Australia
8.5 Rest of the World
8.5.1 Overview
8.5.2 Brazil
8.5.3 Middle East

9. Competitive Landscape

10. Vendors Profile
10.1 GlaxoSmithKline plc
10.1.1 Overview
10.1.2 Geographic Presence
10.1.3 Business Focus
10.1.4 SWOT Analysis
10.1.5 Business Strategy
10.2 Meditas
10.2.1 Overview
10.3 Sleeping Well LLC
10.3.1 Overview
10.4 Apnea Sciences Corporation
10.4.1 Overview
10.5 SomnoMed Ltd.
10.5.1 Overview
10.6 Tomed GmbH
10.6.1 Overview
10.7 MPowerx
10.7.1 Overview
10.8 Theravent
10.8.1 Overview
10.9 Sleep Well Enjoy Life Ltd
10.9.1 Overview
10.10 Rhinomed Ltd
10.10.1 Overview
10.10.2 Highlights
10.11 Hivox Biotek Inc.
10.11.1 Overview
10.12 ZYPPAH
10.12.1 Overview
Annexure
Abbreviations

List of Tables:
Table 1 Cost Comperision of Various Treatment for Snoring
Table 2 Mandibular Advancement Devices (MaD) Available in the Market
Table 3 Top 3 Nasal Dilators in the Market Are
Table 4 Anti-Snoring Devices Market Revenue by Regions, 2017-2024 ($Million)
Table 5 Glaxosmithkline PLC: Offerings
Table 6 Glaxosmithkline PLC: Recent Developments
Table 7 Meditas: Overview
Table 8 Sleeping Well Llc: Overview
Table 9 Apnea Science Corporation: Overview
Table 10 Somnomed Ltd.: Overview
Table 11 Somnomed Ltd.: Recent Developments
Table 12 Tomed Gmbh: Overview
Table 13 Mpowerx: Overview
Table 14 Theravent: Overview
Table 15 Sleep Well Enjoy Life Ltd: Overview
Table 16 Rhinomed Ltd: Overview
Table 17 Hivox Biotek Inc: Overview
Table 18 Zyppah: Overview

List of Charts:
Chart 1 Research Methodology of Global Anti-Snoring Devices Market
Chart 2 Global Anti-Snoring Devices Market Revenue, 2017-2024($Million)
Chart 3 Segmentation of Global Anti-Snoring Devices Market
Chart 4 Porter 5 Forces of Global Anti-Snoring Devices Market
Chart 5 Pest Analysis of Anti-Snoring Devices Market
Chart 6 Market Dynamics - Dro Analysis
Chart 7 Dro - Impact Analysis of Global Anti-Snoring Devices Market
Chart 8 Key Stakeholders
Chart 9 Anti-Snoring Devices Market Segment Share, 2016 (%)
Chart 10 Global Anti-Snoring Devices Market by End-User Segmentation, 2017
Chart 11 Prevalance of Habitual Snorering in Various Countries-2015
Chart 12 Global Anti-Snoring Devices Market by Regional Segmentation, 2016 (%)
Chart 13 Global Anti-Snoring Devices Market by Regional Segmentation, 2016 (%)
Chart 14 Anti-Snoring Devices Market Revenue in North America, 2017-2024 ($Million)
Chart 15 Anti-Snoring Devices Market Revenue in Europe, 2017-2024 ($Million)
Chart 16 Anti-Snoring Devices Market Revenue in Asia Pacific, 2017-2024 ($Million)
Chart 17 Anti-Snoring Devices Market Revenue in Rest of the World, 2017-2024 ($Million)
Chart 18 Glaxosmithkline PLC: Overview Snapshot
Chart 19 Glaxosmithkline PLC: Business Units
Chart 20 Glaxosmithkline PLC: Geographic Presence
Chart 21 Glaxosmithkline PLC: SWOT Analysis
Note: Product cover images may vary from those shown
3 of 6

Loading
LOADING...

4 of 6
  • Apnea Sciences Corporation
  • GlaxoSmithKline plc
  • Hivox Biotek Inc.
  • Meditas
  • MPowerx
  • Rhinomed Ltd
  • Sleep Well Enjoy Life Ltd
  • Sleeping Well LLC
  • SomnoMed Ltd.
  • Theravent
  • Tomed GmbH
  • ZYPPAH
Note: Product cover images may vary from those shown
5 of 6
6 of 6
Note: Product cover images may vary from those shown
Adroll
adroll